Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-028247
Filing Date
2025-02-26
Accepted
2025-02-26 21:56:14
Documents
1
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7252
  Complete submission text file 0000950170-25-028247.txt   8733
Mailing Address C/O VIACELL, INC. 245 FIRST STREET CAMBRIDGE MA 02142
Business Address
Thistle Mary (Reporting) CIK: 0001317917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38433 | Film No.: 25672524

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Issuer) CIK: 0001661998 (see all company filings)

EIN.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)